Bharat Biotech

COVID-19 Vaccine: What We Stand to Lose If ICMR Gets Its ‘Express’ Clinical Trial

Indian Academy of Sciences Calls ICMR’s August 15 Vaccine Deadline ‘Unfeasible’

PIB Version of Ministry Release Cuts Lines on Low Chance of Vaccine Before 2021

ICMR Claims It’s Fast-Tracking COVAXIN to Cut ‘Unnecessary Red Tape’

COVID-19: ICMR’s Rush to Produce ‘Indian Vaccine’ Suggests Politics is Driving Science

A COVID-19 Vaccine for India Is Only a Part of the Answer

Some vaccines are easy to access but others require a trip to a government hospital where conditions are poor and wait times long. Credit: ps_sahana/Flickr, CC BY 2.0

India’s First COVID-19 Vaccine Gets DCGI Nod for Human Clinical Trials